SB 431542 hydrate ≥98% (HPLC), powder

: 4-(5-Benzol[1,3]dioxol-5-yl-4-pyrldin-2-yl-1H-imidazol-2-yl)-benzamide hydrate, 4-[4-(1,3-Benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]-benzamide hydrate, 4-[4-(3,4-Methylenedioxyphenyl)-5-(2-pyridyl)-1H-imidazol-2-yl]-benzamide hydrate

: S 0619

: 301836-41-9

: C₂₂H₁₆N₄O₃.xH₂O

: 384.39

: SB 431542 is a small molecule that acts as a specific and selective inhibitor of TGFβ RI, ACTR-IB and ACTR-IC (transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, 5, and 7).

: S 0619 (OTTO) SB 431542 hydrate ≥98% (HPLC), powder Cas 301836-41-9 - used to study the correlation of platelet-derived growth factor receptor B expression and TGF-β pathway activation in colorectal tumor cells. S 0619 (OTTO) SB 431542 hydrate ≥98% (HPLC), powder Cas 301836-41-9 - used to study the role of TGF-β signaling in modulation of extracellular matrix and myoblast differentiation.